Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06979154 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pilot Study of Personalized Aperiodic Transcranial Alternating Current Stimulation in Antenatal Depression (PandA-tACS)

Study acronym: PandA-tACS
StatusTerminated
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Reclassified as terminated (was completed) Sponsor's reason: Due to lack of resources the study was terminated. Results posted: Sep 28, 2026 · Primary endpoints revised (6) · Eligibility criteria expanded, about 63 words · 1 more Show 4 more changesShow less
    • Results posted: Sep 28, 2026
    • Primary endpoints revised (6)
    • Eligibility criteria expanded, about 63 words
    • Collaborators: details revised at 1 of 2 entries
  2. Trial status: Completed to Terminated Primary endpoints revised (6) · Sponsor's reason: Due to lack of resources the study was terminated. · Eligibility criteria expanded, about 19 words · 1 morev7 Show 4 more changesShow less
    • Primary endpoints revised (6)
    • Sponsor's reason: Due to lack of resources the study was terminated.
    • Eligibility criteria expanded, about 19 words
    • Study description expanded, about 7 words

    See this version in full on ClinicalTrials.gov ↗

  3. Enrollment reduced: 10 → 6 participants Trial completed · Primary and study completion moved earlier from Dec 1, 2026 to Jun 29, 2026 · Site details revisedv6 Show 3 more changesShow less
    • Trial completed
    • Primary and study completion moved earlier from Dec 1, 2026 to Jun 29, 2026
    • Site details revised
  4. Eligibility criteria revisedv5 See this version in full on ClinicalTrials.gov ↗
  5. Re-verified, no change to tracked fieldsv4
Show 2 earlier versionsHide 2 earlier versions
  1. Start date changed from estimate of Aug 2025 to Aug 12, 2025 Site contact updatedv3 Show 1 more changeShow less
    • Site contact updated
  2. Trial status: Not Yet Recruiting to Recruiting Start date: Jun 1, 2025 to Aug 2025 · Study description expanded, about 13 words · Site details revisedv2 Show 3 more changesShow less
    • Start date: Jun 1, 2025 to Aug 2025
    • Study description expanded, about 13 words
    • Site details revised

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to develop the safety, feasibility, and tolerability of a personalized transcranial alternating current stimulation (tACS) approach in antenatal depression.
Trial Details
NCT Number NCT06979154
Lead Sponsor University of North Carolina, Chapel Hill
Collaborators: Brain & Behavior Research Foundation, Michigan State University
Conditions Antenatal Depression, Major Depressive Disorder, Major Depressive Disorder in Pregnancy, Healthy Controls
Enrollment 6 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov